TCG Crossover GP II, LLC - 30 Jan 2026 SCHEDULE 13G Report for ALX Oncology Holdings Inc. Common Stock, par value $0.001 per share (ALXO)

Filing Manager
TCG Crossover GP II, LLC
Reporting Manager
Chen Yu
Security
ALX Oncology Holdings Inc. Common Stock, par value $0.001 per share
Symbol
ALXO
Shares outstanding
131,432,818 shares
Disclosed Ownership
13,011,849 shares
Ownership
9.9%
Form type
SCHEDULE 13G
Filing time
06 Feb 2026, 16:42:36 UTC
Date of event
30 Jan 2026
SEC
View on sec.gov

Sponsored

Quoteable Key Fact

"TCG Crossover GP II, LLC disclosed 9.9% ownership in ALX Oncology Holdings Inc. Common Stock, par value $0.001 per share (ALXO) on 30 Jan 2026."

Quick Takeaways

  • TCG Crossover GP II, LLC filed SCHEDULE 13G for ALX Oncology Holdings Inc. Common Stock, par value $0.001 per share (ALXO).
  • Disclosed ownership: 9.9%.
  • Date of event: 30 Jan 2026.

What Changed

  • No earlier schedule filing is available for direct comparison.
  • Current filing was accepted on 06 Feb 2026, 16:42.

Why This Matters

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Official SEC Source

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (5)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
TCG Crossover GP II, LLC 5% 6,505,925 0 6,505,925 /s/ Craig Skaling Craig Skaling, Authorized Signatory
TCG Crossover Fund II, L.P. 5% 6,505,925 0 6,505,925 /s/ Craig Skaling Craig Skaling, Authorized Signatory
TCG Crossover GP III, LLC 5% 6,505,924 0 6,505,924 /s/ Craig Skaling Craig Skaling, Authorized Signatory
TCG Crossover Fund III, L.P. 5% 6,505,924 0 6,505,924 /s/ Craig Skaling Craig Skaling, Authorized Signatory
Chen Yu 9.9% 13,011,849 0 13,011,849 /s/ Craig Skaling Craig Skaling, as Attorney-in-Fact for Chen Yu

Sponsored